Search results
Sun Pharma completes Taro merger, acquires all outstanding shares
Business Standard India· 4 days agoSun Pharmaceutical Industries on Monday announced the successful completion of the merger of Taro...
Cash Trade: Sun Pharma has given a trendline breakout after forming a short-term bottom
CNBC Awaaz· 1 day agoRSI has given a trendline breakout and MACD has formed a bullish crossover in Sun Pharma
Sun Pharma completes merger of Taro
The Economic Times· 4 days agoSun Pharma on Monday announced the completion of the merger of Taro Pharmaceutical Industries Ltd. with its subsidiary. As part of this merger,
Sun Pharma completes Taro merger to make it a wholly-owned private company
Financial Express· 4 days agoAs part of this merger, Sun Pharma acquired all outstanding ordinary shares of Taro other than the...
Sun Pharma completes merger with Taro - ET HealthWorld | Pharma
The Economic Times· 4 days agoAs part of the merger, Sun Pharma has acquired all outstanding ordinary shares of Taro other than...
Sun Pharma completes Taro merger in a deal valued at $348 million - Times of India
The Times of India· 4 days agoSun Pharma announced the successful completion of the merger of its US subsidiary, Taro...
Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in...
The Economic Times· 7 days agoSun Pharma and Cipla on Friday said they have entered into a non-exclusive patent licensing...
Sun Pharma Completes $347.73 Million Merger, Acquires Full Ownership Of Taro Pharmaceuticals
Free Press Journal· 4 days agoSun Pharmaceuticals Industries Limited, commonly known as Sun Pharma, on Monday, June 24, 2024,...
Top Stocks On D-Street: Sun Pharma, Hindustan Zinc, Bajaj Consumer Among 7 Stocks Lead Todays Market...
Latest India News· 7 days agoRailTel Corporation shares surged nearly 10 per cent, closing at Rs 476.20, driven by a significant increase in trading volume.
Sun Pharma finalizes fusion with Taro Pharmaceuticals - India Telecom News
India Telecom News· 4 days agoSun Pharmaceutical Industries has completed the merger with Taro Pharmaceutical Industries, ending a long feud. Taro will be delisted from NYSE and will be 100% owned by & ...
